NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/07/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.55 mln
Float1.79 mln
Earnings Date08/14/2026
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
83
/ 100
Strongly outperforming
Debt / Equity
0.00
Debt-free
ROE
-55.90
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Bone Biologics Corporation is a US-based medical company founded in 2004 and headquartered in Burlington, Massachusetts, that develops advanced solutions for spinal bone regeneration. Its main product, NELL-1/DBM, uses a lab-engineered protein to promote precise and targeted bone growth, with applications in spinal fusion, trauma cases, and osteoporosis treatment. The company holds a licensing agreement with UCLA to develop and bring these treatments to market, ultimately serving spine surgeons and patients dealing with bone defects or spinal conditions.
